What is presbyopia?

Article

Sean W. Smolenyak, OD, gives a brief overview of presbyopia, including the cause and available treatments.

The gradual loss of your eyes ability to focus on near objects is called presbyopia (pronounced prez-by-opia). It typically occurs as a person enters their 40s, making it one of the most common aging conditions of the eye. For some it is very annoying and can negatively impact their daily activities.

The primary reason this occurs is because the natural lens inside the eye becomes less flexible with time. This loss of flexibility reduces the eye’s ability to change focus both in terms of speed (changing focus from far away to up-close quickly), as well as overall focusing power (maintaining clarity on an object up close). Since the lens does not flex as well as it did, light is not focused properly on the retina (the lining on the back of the eye that absorbs light).

For most people, it is a gradual process that worsens over time, typically years. However, I have had a few patients over the years report it seemed to happen almost overnight.

There are several things that we do to compensate for these difficulties including increasing font size on screens, increasing ambient lighting and screen brightness, as well as holding things farther away (or not so close). In addition, many patients turn to either over-the-counter reading glasses or change their distance prescription glasses to bifocal, trifocals, or progressive lenses.

Recent advances in managing presbyopia have revolved around lens implants and eyedrops. Lens implantation, typically at the time of cataract surgery, offers patients the ability to choose an implant that helps not only with distance vision but allows for an extended depth of focus with near tasks, including computer and reading.

Even more recently, the FDA approved the first eyedrop, VUITY (Allergan) to help mitigate the effects of presbyopia on a patient’s daily activities. Studies show VUITY can improve computer and reading ability with less dependency on glasses. Not every patient is a candidate for an implant or VUITY, so it is best to consult with your eyecare provider during a comprehensive, dilated eye exam. More advances in eyedrops are expected in the coming years as more companies bring products to market.

Aging changes to the eye can be scary and negatively impact daily activities. With recent advances—and more to come—presbyopia is proving not to be as difficult to manage as in years gone by.

Recent Videos
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
Ashley Wallace Tucker, OD, FAAO, FSLS, Dipl ABO, weighs in on what's on the horizon for pediatric myopia management, and provides some tips for diving into scleral lens fitting.
Shan Lin, MD, outlines a new generation of minimally invasive glaucoma surgeries (MIGS) at Glaucoma 360.
Walline, OD, PhD, FAAO, outlines how to predict myopia progression and delay its onset in an exclusive interview with Optometry Times.
Jeffrey Walline, OD, PhD, FAAO, overviews a presentation he gave on the Bifocal Lenses in Nearsighted Kids 2 (BLINK2) cohort study at the Collaborative Community on Ophthalmic Innovation (CCOI).
Walline, OD, PhD, FAAO, states that the best way to learn the benefits of artificial intelligence for your practice is to stay on top of continuing education attendance.
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
© 2025 MJH Life Sciences

All rights reserved.